Anticonvulsant medicine supply warning issued
A medicine supply warning for the anticonvulsant medicine, midazolam – commonly sold as epistatus – has been issued by the Department of Health and Social Care (DHSC).
On 5 May, the DHSC issued a tier 2 – medium impact – medicine supply notification stating that midazolam (epistatus) 7.5mg/0.75ml oromucosal solution pre-filled oral syringes sugar free are currently out of stock until late-May 2026.
The notification also states that midazolam (buccolam and generic) 7.5mg/1.5ml oromucosal solution pre-filled oral syringes remain available and can support increased demand.
Epistatus is typically used to stop a prolonged, acute convulsive seizure in adults, adolescents, children and infants aged 3 months and above.
A copy of this medicine supply notification, including supporting information, has been sent to all pharmacy NHS email addresses.
Keep your clinical knowledge up to date with The Pharmacist
Extend your learning and record your learning outcomes
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.